Home›Companies›Biotech & Pharma›Hydrocision

Hydrocision Inc.

Updated Oct 29, 2026·Latest SEC filing Apr 1, 2025·Suggest an edit

About Hydrocision

Hydrocision is a private company based in North Billerica, Massachusetts. It has reported $9,178,847 raised in four offerings on Form D since September 2009.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 15, 2024Apr 1, 2025$2,530,912of $3.8M target12$210KEquityRule 506(b)Form D ↗
Mar 9, 2017Mar 24, 2017$3,000,000of $4.0M target10$300KEquityRule 506(b)Form D ↗
Mar 30, 2010Apr 14, 2010$623,635of $700K target8$77,954Debt, Options06Form D ↗
Nov 18, 2008Sep 11, 2009$3,024,300of $4.5M target11$274KDebt, Options06Form D/A ↗
Total, four offerings$9,178,847

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Hydrocision's Form D filed Apr 1, 2025.

PK
Paul Kowalski
Executive officer
DW
Doug Wall
Director
TW
Terry Wall
Director
LZ
Long Zhan
Director
BG
Bryan Grulke
Director
HD
RI
Richard Lytle, III
Executive officer and director
TA
Thomas Abert
Treasurer
MG

Earlier filings also listed Yu Xiaotong (director, last listed Mar 2017), Patricia Van Blarcom (cfo, last listed Mar 2017), Richard Lim (director, last listed Apr 2010), Jonathan Fleming (director, last listed Apr 2010), Douglas Daniels (president and ceo, director, last listed Apr 2010), Alastair Clemow PhD (director, last listed Apr 2010), Lew Bennett (director, last listed Sep 2009) and Kevin Staid (executive officer, last listed Sep 2009).

Sources

  1. SECHYDROCISION INC filing history